The New Digital Divide For Digital Biomarkers

Torous, John; Rodriguez, Jorge A.; Powell, Adam C.

doi:10.1159/000477382

Cited by 48 publications

(30 citation statements)

References 19 publications

(20 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…3 Although much remains unknown about exactly who is using mental health apps, it is clear that many are interested and likely trying them. 4 In 2015, a national survey noted that mental health apps were in the top three categories of health apps downloaded. 5 Apps have the potential to increase access to care for people who might not otherwise seek professional care, as patients may use apps independently or be encouraged by apps to seek in-person help via app-based screening and diagnosis.…”

Section: Use Of Apps Todaymentioning

confidence: 99%

Generating value with mental health apps

et al. 2020

View full text Add to dashboard Cite

Background Although apps are increasingly being used to support the diagnosis, treatment and management of mental illness, there is no single means through which costs associated with mental apps are being reimbursed. Furthermore, different apps are amenable to different means of reimbursement as not all apps generate value in the same way. Aims To provide insights into how apps are currently generating value and being reimbursed across the world, with a particular focus on the situation in the USA. Method An international team performed secondary research on how apps are being used and on common pathways to remuneration. Results The uses of apps today and in the future are reviewed, the nature of the value delivered by apps is summarised and an overview of app reimbursement in the USA and other countries is provided. Recommendations regarding how payments might be made for apps in the future are discussed. Conclusions Currently, apps are being reimbursed through channels with other original purposes. There may be a need to develop an app-specific channel for reimbursement which is analogous to the channels used for devices, drugs and laboratory tests.

show abstract

Section: Use Of Apps Todaymentioning

confidence: 99%

Generating value with mental health apps

et al. 2020

View full text Add to dashboard Cite

show abstract

“…While there are many challenges that need to be addressed before the widespread deployment of such technologies, one particular element of concern is patient privacy and trust [72,73,75]. Indeed, information privacy, the overall ability of an individual to control their own information, is a considerable concern with regard to health-related assistive technology in general [76].…”

Section: Potential Applications Of Blockchain Technologies In the Heamentioning

confidence: 99%

Overcoming Alzheimer’s Disease Stigma by Leveraging Artificial Intelligence and Blockchain Technologies

Pilozzi

Huang

2020

Brain Sciences

View full text Add to dashboard Cite

Alzheimer’s disease (AD) imposes a considerable burden on those diagnosed. Faced with a neurodegenerative decline for which there is no effective cure or prevention method, sufferers of the disease are subject to judgement, both self-imposed and otherwise, that can have a great deal of effect on their lives. The burden of this stigma is more than just psychological, as reluctance to face an AD diagnosis can lead people to avoid early diagnosis, treatment, and research opportunities that may be beneficial to them, and that may help progress towards fighting AD and its progression. In this review, we discuss how recent advents in information technology may be employed to help fight this stigma. Using artificial intelligence (AI) technologies, specifically natural language processing (NLP), to classify the sentiment and tone of texts, such as those of online posts on various social media sites, has proven to be an effective tool for assessing the opinions of the general public on certain topics. These tools can be used to analyze the public stigma surrounding AD. Additionally, there is much concern among individuals that an AD diagnosis, or evidence of pre-clinical AD such as a biomarker or imaging test results, may wind up unintentionally disclosed to an entity that may discriminate against them. The lackluster security record of many medical institutions justifies this fear to an extent. Adopting more secure and decentralized methods of data transfer and storage, and giving patients enhanced ability to control their own data, such as a blockchain-based method, may help to alleviate some of these fears.

show abstract

“…While not the primary focus of the Forum, a number of broader policy issues were identified that are linked to regulatory science needs and opportunities to advance digital health [33,34]. One concern is that access to and understanding of digital health technologies can lead to disparities and issues of fairness, potentially perpetuating biases and continuing and exacerbating a "digital divide" [35][36][37].…”

Section: Broader Policy-related Issuesmentioning

confidence: 99%

Translation of Digital Health Technologies to Advance Precision Medicine: Informing Regulatory Science

et al. 2020

View full text Add to dashboard Cite

The proliferation of digital technologies and the application of sophisticated data analysis techniques are increasingly viewed as having the potential to transform translational research and precision medicine. While digital technologies are rapidly applied in innovative ways to develop new diagnostics and therapies, the ultimate approval and adoption of these emerging methods presents several scientific and regulatory challenges. To better understand and address these regulatory science gaps, a working group of the Clinical and Translational Science Awards Program convened the Regulatory Science to Advance Precision Medicine Forum focused on digital health, particularly examining gaps in the use, validation, and interpretation of data from sensors that collect and tools that analyze digital biomarkers. The key findings and recommendations provided here emerged from the Forum and include the need to enhance areas related to data standards, data quality and validity, knowledge management, and building trust between all stakeholders.

show abstract

The New Digital Divide For Digital Biomarkers

Cited by 48 publications

References 19 publications

Generating value with mental health apps

Generating value with mental health apps

Overcoming Alzheimer’s Disease Stigma by Leveraging Artificial Intelligence and Blockchain Technologies

Translation of Digital Health Technologies to Advance Precision Medicine: Informing Regulatory Science

Contact Info

Product

Resources

About